Influence of Late Treatment on How Chronic Myeloid Leukemia Responds to Imatinib

INTRODUCTION: In Brazil, patients with chronic myeloid leukemia (CML) in the chronic phase were not given first-line imatinib treatment until 2008. Therefore, there was a long period of time between diagnosis and the initiation of imatinib therapy for many patients. This study aims to compare the ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Scerni, Ana Carolina Costa, Alvares, Leonardo Azevedo, Beltrão, Ana Cristina, Bentes, Iê Regina, Azevedo, Tereza Cristina, Bentes, Alessandra Quinto, Lemos, José Alexandre Rodrigues
Formato: Texto
Lenguaje:English
Publicado: Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2009
Materias:
Clinical Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2728184/
https://www.ncbi.nlm.nih.gov/pubmed/19690655
http://dx.doi.org/10.1590/S1807-59322009000800004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2728184/
https://www.ncbi.nlm.nih.gov/pubmed/19690655
http://dx.doi.org/10.1590/S1807-59322009000800004

Ejemplares similares